Assessing a Healthcare Program/Policy Evaluation

Assessing a Healthcare Program/Policy Evaluation

Healthcare Program/Policy Evaluation Analysis Template

 

Use this document to complete the Module 5 Assessment
Assessing a Healthcare Program/Policy Evaluation

Joan Wade

 

 

 

Healthcare Program/Policy Evaluation

 

Massachusetts Health Policy Commission: Health Care Cost Growth Benchmark Policy Evaluation

Description

The Massachusetts Health Policy Commission (HPC) is a state agency created to address healthcare costs while maintaining quality. Massachusetts was the first state to use this approach in 2012, with the HPC being responsible for collecting data on health care costs and setting a yearly cost growth benchmark (Chen, 2025).

How was the success of the program or policy measured?

 

 

The primary indicator is keeping annual spending increases at or below the specified target. Secondary outcomes include increased transparency and greater accountability among payers and providers, and a shift toward prevention-focused care.

How many people were reached by the program or policy selected? How much of an impact was realized with the program or policy selected?

 

 

Because it applies to all payers and providers, the benchmark affects all 7 million Massachusetts residents, and since 2012, health care cost growth has remained at or near the benchmark in most years, which has resulted in slower premium growth in Massachusetts. For my patients, this means coverage has remained more stable than it would have been otherwise, and the HPC does ongoing evaluations through annual Cost Trends Reports, which represents more than ten years of data.

At what point in program implementation was the program or policy evaluation conducted?

 

The HPC measures have been in place since 2012, and the program has conducted evaluations on a yearly basis, using data submitted from many sources. The policy evaluations are provided annually in the HPC’s annual Cost Trends Reports and at public forums, during which stakeholder input is gathered. The reports themselves represent more than ten years of data.

What data was used to conduct the program or policy evaluation?

 

 

The HPC measures success by tracking whether total health care expenditures remain at or below the annual benchmark. Data sources include claims from commercial insurers, MassHealth, and Medicare, along with enrollment data, premium information, and prescription drug spending. The HPC also monitors quality indicators and regional variation in high-cost services (Berger & Czypionka, 2021). The HPC does ongoing evaluations through annual Cost Trends Reports.

What specific information on unintended consequences were identified?

 

Secondary outcomes include increased transparency and greater accountability among payers and providers, and a shift toward prevention-focused care. The HPC’s standards have unintended consequences, and some providers worry that cost containment limits investment in technology and workforce development. There is also the concern that cost pressures will reduce access in underserved areas if providers close clinics in lower-margin communities. Digital access is very important, and moving to online healthcare can harm equity if it goes forward without addressing the consumers’ access to online content, which requires planning (Lyles et al., 2021).

What stakeholders were identified in the evaluation of the program or policy? Who would benefit most from the results and reporting of the program or policy evaluation? Be specific and provide examples.

 

 

Stakeholders include state officials, insurers, hospital systems, physician groups, consumer advocates, employers, and patients. The HPC holds annual public hearings where these groups provide input. Those who benefit most from the results and reporting of health policy evaluation include consumer advocacy groups who can hold the system accountable. For example, Health Care For All used ConnectorCare program data showing average premium reductions of $150 per month and improved preventive care access to advocate for extending affordable coverage to over 40,000 residents (Health Care For All, 2026).

Did the program or policy meet the original intent and objectives? Why or why not?

 

 

The HPC has largely met its primary objective. Spending growth has remained at or near target since 2012, but the policy has been less successful in its secondary objectives. Some populations have disparities in access and affordability. Research shows that care that meets the guideline’s standards improves outcomes and reduces ineffective interventions (Lindqvist et al., 2022), but the benchmark alone does not ensure that providers follow evidence-based guidelines. Hospital spending still accounts for a large share of expenditures despite goals to shift care to community settings. However, the Massachusetts model shows that transparent, data-driven accountability can slow cost growth without necessarily reducing quality.

Would you recommend implementing this program or policy in your place of work? Why or why not?

 

 

The HPC’s program is already in place statewide and applies to my hospital by default. It has been successful in achieving its primary goal and has for the most part done so without compromising quality of care. For my patients, this means coverage has remained more stable than it would have been otherwise. However, my interest and that of my patients is more focused on the program’s secondary goals. Healthcare equity must be taken into consideration, not as a secondary goal but as a primary focus. Many patients suffer from disparities in access and affordability, and the policy benchmark does not ensure that providers follow evidence-based care guidelines. That is where I would focus my advocacy efforts.

Identify at least two ways that you, as a nurse advocate, could become involved in evaluating a program or policy after one year of implementation.

 

 

As a nurse advocate, I plan to participate in the HPC’s annual Cost Trends Hearing process by attending public hearings and submitting testimony that presents the perspectives of patients and front-line clinicians. The HPC actively solicits input from the public, and nurses have direct insight into how cost pressures affect care at the bedside. For example, I could testify about how my patients face barriers to access or affordability that the cost data does not capture.

 

I also plan to work with quality improvement teams in my organization to collect and analyze data on how the benchmark affects clinical outcomes and patients, especially among underserved populations. We could design surveys to assess whether patients have experienced changes in access to care or out-of-pocket costs since the benchmark was implemented. Data collection that tracks equity indicators would help ensure that vulnerable patients’ needs are reflected in the evaluation process.

General Notes/Comments

The Massachusetts HPC’s cost growth benchmark is a clear way to evaluate healthcare spending. It helps policymakers to track cost trends and provides a transparent view of how that control affects our patients. The benchmark has largely achieved its primary objective of cost control, but it’s important that we continue to pay attention to its effect on healthcare equity. As a nurse advocate, I am committed to ensuring that cost containment keeps patients at the center of policy decisions.

 

 

References

Berger, M., & Czypionka, T. (2021). Regional medical practice variation in high-cost healthcare services.
The European Journal of Health Economics, 22
(6), 917-929. https://doi.org/10.1007/s10198-021-01298-w

Chen, L. J. (2025). The problem with California’s plan to contain health care costs.
JAMA Health Forum, 6
(7), e253383. https://doi.org/10.1001/jamahealthforum.2025.3383

Health Care For All. (2026, January 29). Press statement: Health Care For All reacts to Governor Healey’s budget plan [Press release]. https://hcfama.org/press-statement-health-care-for-all-reacts-to-governor-healeys-budget-plan-january-29-2026/

Lindqvist, J., Jekunen, A., Sihvo, E., Johansson, M., & Andersén, H. (2022). Effect of adherence to treatment guidelines on overall survival in elderly non-small-cell lung cancer patients.
Lung Cancer, 171
, 9-17. https://doi.org/10.1016/j.lungcan.2022.07.006

Lyles, C. R., Wachter, R. M., & Sarkar, U. (2021). Focusing on digital health equity.
JAMA, 326
(18):1795-1796. https://doi.org/10.1001/jama.2021.18459 Assessing a Healthcare Program/Policy Evaluation